Copyright Reports & Markets. All rights reserved.

Global Epirubicin Hydrochloride Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Epirubicin Hydrochloride Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 10mg/5ml
    • 1.3.3 50mg/25ml
    • 1.3.4 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Epirubicin Hydrochloride Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Cancer
    • 1.4.3 Others
  • 1.5 Global Epirubicin Hydrochloride Market Size & Forecast
    • 1.5.1 Global Epirubicin Hydrochloride Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Epirubicin Hydrochloride Sales Quantity (2021-2032)
    • 1.5.3 Global Epirubicin Hydrochloride Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Sterling Biotech
    • 2.1.1 Sterling Biotech Details
    • 2.1.2 Sterling Biotech Major Business
    • 2.1.3 Sterling Biotech Epirubicin Hydrochloride Product and Services
    • 2.1.4 Sterling Biotech Epirubicin Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sterling Biotech Recent Developments/Updates
  • 2.2 Zhejiang Hisun Pharma
    • 2.2.1 Zhejiang Hisun Pharma Details
    • 2.2.2 Zhejiang Hisun Pharma Major Business
    • 2.2.3 Zhejiang Hisun Pharma Epirubicin Hydrochloride Product and Services
    • 2.2.4 Zhejiang Hisun Pharma Epirubicin Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Zhejiang Hisun Pharma Recent Developments/Updates
  • 2.3 Flavine
    • 2.3.1 Flavine Details
    • 2.3.2 Flavine Major Business
    • 2.3.3 Flavine Epirubicin Hydrochloride Product and Services
    • 2.3.4 Flavine Epirubicin Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Flavine Recent Developments/Updates
  • 2.4 Teva API
    • 2.4.1 Teva API Details
    • 2.4.2 Teva API Major Business
    • 2.4.3 Teva API Epirubicin Hydrochloride Product and Services
    • 2.4.4 Teva API Epirubicin Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Teva API Recent Developments/Updates
  • 2.5 Microbiopharm Japan
    • 2.5.1 Microbiopharm Japan Details
    • 2.5.2 Microbiopharm Japan Major Business
    • 2.5.3 Microbiopharm Japan Epirubicin Hydrochloride Product and Services
    • 2.5.4 Microbiopharm Japan Epirubicin Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Microbiopharm Japan Recent Developments/Updates
  • 2.6 DZD Heze Pharma
    • 2.6.1 DZD Heze Pharma Details
    • 2.6.2 DZD Heze Pharma Major Business
    • 2.6.3 DZD Heze Pharma Epirubicin Hydrochloride Product and Services
    • 2.6.4 DZD Heze Pharma Epirubicin Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 DZD Heze Pharma Recent Developments/Updates
  • 2.7 Synbias Pharma
    • 2.7.1 Synbias Pharma Details
    • 2.7.2 Synbias Pharma Major Business
    • 2.7.3 Synbias Pharma Epirubicin Hydrochloride Product and Services
    • 2.7.4 Synbias Pharma Epirubicin Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Synbias Pharma Recent Developments/Updates
  • 2.8 Intas Pharma
    • 2.8.1 Intas Pharma Details
    • 2.8.2 Intas Pharma Major Business
    • 2.8.3 Intas Pharma Epirubicin Hydrochloride Product and Services
    • 2.8.4 Intas Pharma Epirubicin Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Intas Pharma Recent Developments/Updates
  • 2.9 Humble Healthcaare
    • 2.9.1 Humble Healthcaare Details
    • 2.9.2 Humble Healthcaare Major Business
    • 2.9.3 Humble Healthcaare Epirubicin Hydrochloride Product and Services
    • 2.9.4 Humble Healthcaare Epirubicin Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Humble Healthcaare Recent Developments/Updates
  • 2.10 Lunan Pharmaceutical Group
    • 2.10.1 Lunan Pharmaceutical Group Details
    • 2.10.2 Lunan Pharmaceutical Group Major Business
    • 2.10.3 Lunan Pharmaceutical Group Epirubicin Hydrochloride Product and Services
    • 2.10.4 Lunan Pharmaceutical Group Epirubicin Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Lunan Pharmaceutical Group Recent Developments/Updates
  • 2.11 Pfizer
    • 2.11.1 Pfizer Details
    • 2.11.2 Pfizer Major Business
    • 2.11.3 Pfizer Epirubicin Hydrochloride Product and Services
    • 2.11.4 Pfizer Epirubicin Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Pfizer Recent Developments/Updates
  • 2.12 Beijing Union Pharmaceutical Factory
    • 2.12.1 Beijing Union Pharmaceutical Factory Details
    • 2.12.2 Beijing Union Pharmaceutical Factory Major Business
    • 2.12.3 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Product and Services
    • 2.12.4 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Beijing Union Pharmaceutical Factory Recent Developments/Updates

3 Competitive Environment: Epirubicin Hydrochloride by Manufacturer

  • 3.1 Global Epirubicin Hydrochloride Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Epirubicin Hydrochloride Revenue by Manufacturer (2021-2026)
  • 3.3 Global Epirubicin Hydrochloride Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Epirubicin Hydrochloride by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Epirubicin Hydrochloride Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Epirubicin Hydrochloride Manufacturer Market Share in 2025
  • 3.5 Epirubicin Hydrochloride Market: Overall Company Footprint Analysis
    • 3.5.1 Epirubicin Hydrochloride Market: Region Footprint
    • 3.5.2 Epirubicin Hydrochloride Market: Company Product Type Footprint
    • 3.5.3 Epirubicin Hydrochloride Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Epirubicin Hydrochloride Market Size by Region
    • 4.1.1 Global Epirubicin Hydrochloride Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Epirubicin Hydrochloride Consumption Value by Region (2021-2032)
    • 4.1.3 Global Epirubicin Hydrochloride Average Price by Region (2021-2032)
  • 4.2 North America Epirubicin Hydrochloride Consumption Value (2021-2032)
  • 4.3 Europe Epirubicin Hydrochloride Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Epirubicin Hydrochloride Consumption Value (2021-2032)
  • 4.5 South America Epirubicin Hydrochloride Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Epirubicin Hydrochloride Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Epirubicin Hydrochloride Sales Quantity by Type (2021-2032)
  • 5.2 Global Epirubicin Hydrochloride Consumption Value by Type (2021-2032)
  • 5.3 Global Epirubicin Hydrochloride Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Epirubicin Hydrochloride Sales Quantity by Application (2021-2032)
  • 6.2 Global Epirubicin Hydrochloride Consumption Value by Application (2021-2032)
  • 6.3 Global Epirubicin Hydrochloride Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Epirubicin Hydrochloride Sales Quantity by Type (2021-2032)
  • 7.2 North America Epirubicin Hydrochloride Sales Quantity by Application (2021-2032)
  • 7.3 North America Epirubicin Hydrochloride Market Size by Country
    • 7.3.1 North America Epirubicin Hydrochloride Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Epirubicin Hydrochloride Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Epirubicin Hydrochloride Sales Quantity by Type (2021-2032)
  • 8.2 Europe Epirubicin Hydrochloride Sales Quantity by Application (2021-2032)
  • 8.3 Europe Epirubicin Hydrochloride Market Size by Country
    • 8.3.1 Europe Epirubicin Hydrochloride Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Epirubicin Hydrochloride Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Epirubicin Hydrochloride Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Epirubicin Hydrochloride Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Epirubicin Hydrochloride Market Size by Region
    • 9.3.1 Asia-Pacific Epirubicin Hydrochloride Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Epirubicin Hydrochloride Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Epirubicin Hydrochloride Sales Quantity by Type (2021-2032)
  • 10.2 South America Epirubicin Hydrochloride Sales Quantity by Application (2021-2032)
  • 10.3 South America Epirubicin Hydrochloride Market Size by Country
    • 10.3.1 South America Epirubicin Hydrochloride Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Epirubicin Hydrochloride Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Epirubicin Hydrochloride Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Epirubicin Hydrochloride Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Epirubicin Hydrochloride Market Size by Country
    • 11.3.1 Middle East & Africa Epirubicin Hydrochloride Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Epirubicin Hydrochloride Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Epirubicin Hydrochloride Market Drivers
  • 12.2 Epirubicin Hydrochloride Market Restraints
  • 12.3 Epirubicin Hydrochloride Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Epirubicin Hydrochloride and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Epirubicin Hydrochloride
  • 13.3 Epirubicin Hydrochloride Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Epirubicin Hydrochloride Typical Distributors
  • 14.3 Epirubicin Hydrochloride Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Epirubicin Hydrochloride market size was valued at US$ 242 million in 2025 and is forecast to a readjusted size of US$ 204 million by 2032 with a CAGR of -2.4% during review period.
    Epirubicin Hydrochloride is the hydrochloride salt of the 4'-epi-isomer of the anthracycline antineoplastic antibiotic doxorubicin. Epirubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis. This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.
    Epirubicin hydrochloride is an anthracycline antitumor antibiotic developed by Pfizer for the treatment of breast cancer, lung cancer, and liver cancer. It was launched in Europe in 1984 and in the United States in 1999. It is widely used in the treatment of leukemia, lymphoma, and various solid tumors (including breast cancer, non-small cell tumors, cervical cancer, and head and neck cancer). Its mechanism of action is to directly embed between DNA nucleobase pairs, interfere with the transcription process, prevent the formation of mRNA, and thus inhibit the synthesis of DNA and RNA. In addition, epirubicin also has an inhibitory effect on topoisomerase II. It is a cell cycle non-specific drug that is effective against a variety of transplanted tumors. Compared with doxorubicin, it has equal or slightly higher efficacy, but is less toxic to the heart.
    Global core Epirubicin Hydrochloride players include Synbias Pharma, Zhejiang Hisun Pharma and Pfizer etc. The top 3 companies hold a share about 60%. Asia-Pacific is the largest market, with a share about 45%, followed by Europe and North America with the share about 25% and 20%. In terms of product, 10mg/5ml is the largest segment, with a share about 45%, followed by 50mg/25ml, with a share about 40%. And in terms of application, the largest application is cancer, with a share about 95%, followed by others, with a share about 5%.
    This report is a detailed and comprehensive analysis for global Epirubicin Hydrochloride market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Epirubicin Hydrochloride market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2021-2032
    Global Epirubicin Hydrochloride market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2021-2032
    Global Epirubicin Hydrochloride market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2021-2032
    Global Epirubicin Hydrochloride market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Epirubicin Hydrochloride
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Epirubicin Hydrochloride market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sterling Biotech, Zhejiang Hisun Pharma, Flavine, Teva API, Microbiopharm Japan, DZD Heze Pharma, Synbias Pharma, Intas Pharma, Humble Healthcaare, Lunan Pharmaceutical Group, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Epirubicin Hydrochloride market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    10mg/5ml
    50mg/25ml
    Other
    Market segment by Application
    Cancer
    Others
    Major players covered
    Sterling Biotech
    Zhejiang Hisun Pharma
    Flavine
    Teva API
    Microbiopharm Japan
    DZD Heze Pharma
    Synbias Pharma
    Intas Pharma
    Humble Healthcaare
    Lunan Pharmaceutical Group
    Pfizer
    Beijing Union Pharmaceutical Factory
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Epirubicin Hydrochloride product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Epirubicin Hydrochloride, with price, sales quantity, revenue, and global market share of Epirubicin Hydrochloride from 2021 to 2026.
    Chapter 3, the Epirubicin Hydrochloride competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Epirubicin Hydrochloride breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Epirubicin Hydrochloride market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Epirubicin Hydrochloride.
    Chapter 14 and 15, to describe Epirubicin Hydrochloride sales channel, distributors, customers, research findings and conclusion.

    Buy now